Open Access

[Corrigendum] Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK/ERK1/2 and PI3K/Akt signaling pathways

  • Authors:
    • Chiachen Chen
    • Yuan-Ching Chang
    • Michael S. Lan
    • Mary Breslin
  • View Affiliations

  • Published online on: June 6, 2016     https://doi.org/10.3892/ijo.2016.3564
  • Pages: 847-847
  • Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

View Figures

Related Articles

Journal Cover

August-2016
Volume 49 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chen C, Chang Y, Lan MS and Breslin M: [Corrigendum] Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK/ERK1/2 and PI3K/Akt signaling pathways. Int J Oncol 49: 847-847, 2016
APA
Chen, C., Chang, Y., Lan, M.S., & Breslin, M. (2016). [Corrigendum] Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK/ERK1/2 and PI3K/Akt signaling pathways. International Journal of Oncology, 49, 847-847. https://doi.org/10.3892/ijo.2016.3564
MLA
Chen, C., Chang, Y., Lan, M. S., Breslin, M."[Corrigendum] Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK/ERK1/2 and PI3K/Akt signaling pathways". International Journal of Oncology 49.2 (2016): 847-847.
Chicago
Chen, C., Chang, Y., Lan, M. S., Breslin, M."[Corrigendum] Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK/ERK1/2 and PI3K/Akt signaling pathways". International Journal of Oncology 49, no. 2 (2016): 847-847. https://doi.org/10.3892/ijo.2016.3564